10-Q quarterly report · filed Nov 3, 2026

Henry Schein (HSIC) Q3 2026 10-Q Quarterly Report

Short answer

Henry Schein (HSIC) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 26, 2026. Quarterly revenue was $3.5B (up 4.0% year over year) with net income of $119M.

Q3 2026 key financials · XBRL

Revenue
$3.5B
+4.0% YoY · +0.4% QoQ
Net income
$119M
+17.8% YoY · +26.6% QoQ
Operating margin
5.6%
Gross margin
31.8%
EPS (diluted)
$1.06
+26.2% YoY · +29.3% QoQ

Source: XBRL data from the Henry Schein (HSIC) Q3 2026 10-Q on SEC EDGAR. USD.

Henry Schein Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $3,471M, up 4.0% YoY from $3,339M
  • Gross margin 31.8% vs 30.7% YoY, with effective tax rate 23.1% vs 21.3%
  • Best segment Global Specialty Products, sales up 6.1% to 11.3% of revenue
  • Worst product line Global Value-Added Services, sales down 4.8%
  • Nine-month operating cash flow $306M vs $331M, investing cash use $173M vs $253M
  • Tariff refund benefit $28M in quarter, additional refunds expected in fourth quarter of 2026

Risk Factors

  • No material changes from the December 27, 2025 Form 10-K risk factors
  • Continued exposure to healthcare distribution competition and pricing pressure
  • Continued regulatory and compliance requirements across healthcare markets
  • Continued liquidity, credit, and foreign-currency risks from global operations

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Henry Schein quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.